Businesses are constantly faced with the challenge of keeping pace with increased innovation. We advise companies looking to make strategic investments in new technologies and commercial partnerships with innovative start-ups to enable them to adapt to the ever-changing marketplace.
Our lawyers are experienced in building from inception, managing and monitoring, and ultimately monetizing, corporate venture capital portfolios. We know what works and what doesn't and what's in market corporate venture capital investments. We have represented corporate venturers, strategic acquirors, VC firms, underwriters, early-stage and emerging growth businesses, and entrepreneurs in all stages of the investment cycle, from formation to exit. Our Silicon Valley presence and firmwide focus on technology, ensures significant exposure to the latest trends and deal terms in a variety of different industries and markets.
Corporate Venture Capital Practice
Due Diligence. We deploy interdisciplinary teams that mix corporate, IP, tax, regulatory and other relevant experience to tackle due diligence review of the target company's business arrangements, assets and liabilities, IP portfolio, R&D process, and compliance efforts. Whenever IP assets are developed or shared, Baker Botts IP lawyers have the technical and business experience to support the transaction. Our diverse due diligence experience spans all areas of technology, engineering, energy and life sciences.
Investment. Baker Botts lawyers are well versed in structuring and executing all manner of CVC investments, whether early, mid or late stage, and understand the intricacies of anti-dilution mechanics, liquidation preferences, voting rights and registration rights. We know what is market for these investments and what CVC investment terms look like. We understand the necessary balance of protecting and maximizing our client’s financial return with promoting and facilitating the target's development of its product or service offerings and commercialization of its business.
Commercial Benefit. We provide creative and comprehensive transaction design, and execution approaches, with both technology and commercial business objectives in mind. We bring to the table 30+ years of tech sector experience advising on strategic commercial alliances, joint development and joint venture arrangements, often involving creative commercial licensing, and supply, marketing and distribution arrangements for critical or innovative technology. Our solutions are business-focused - we recognize each party's desire to maximize value and minimize risk while still creating an commercial relationship that allows for growth as business needs change.
Our CVC team integrates seamlessly with the firm's nationally ranked M&A and capital markets practices, helping our clients on their CVC investment.
Moderator, Baker Botts Panel Discussion, SXSW 2019
Baker Botts is excited to announce our second annual SXSW event - Mobility Innovation: Eliminating Barriers to Growth.
Baker Botts (UK) LLP, in association with the Digital Health & Care Alliance and Ascendant Corporate Finance, will host its fourth annual Health Technology pitch event on Wednesday 5 February 2020 at the London Baker Botts office.
Baker Botts in partnership with NovAzure Consulting, is delighted to invite you to our 3rd annual Cleantech and Renewables pitch event on Tuesday 15 October 2019 at our London office.